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ABSTRACT
To induce differentiation of embryonic stem cells (ESCs) into
specialized cell types for therapeutic purposes, it may be desir-
able to combine genetic manipulation and appropriate differ-
entiation signals. We studied the induction of dopaminergic
(DA) neurons from mouse ESCs by overexpressing the tran-
scription factor Nurr1 and coculturing with PA6 stromal cells.
Nurr1-expressing ESCs (N2 and N5) differentiated into a
higher number of neurons (twofold) than the naı¨ve ESCs
(D3). In addition, N2/N5-derived cells contained a significantly
higher proportion (>50%) of tyrosine hydroxylase (TH) neu-
rons than D3 (<30%) and an even greater proportion of TH
neurons (90%) when treated with the signaling molecules
sonic hedgehog, fibroblast growth factor 8, and ascorbic acid.
N2/N5-derived cells express much higher levels of DA markers
(e.g., TH, dopamine transporter, aromatic amino acid decar-
boxylase, and G protein–regulated inwardly rectifying K
channel 2) and produce and release a higher level of dopamine,
compared with D3-derived cells. Furthermore, the majority
of generated neurons exhibited electrophysiological proper-
ties characteristic of midbrain DA neurons. Finally, trans-
plantation experiments showed efficient in vivo integration/
generation of TH neurons after implantation into mouse
striatum. Taken together, our results show that the combi-
nation of genetic manipulation(s) and in vitro cell differen-
tiation conditions offers a reliable and effective induction of
DA neurons from ESCs and may pave the way for future cell
transplantation therapy in Parkinson’s disease. STEM
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INTRODUCTION
Embryonic stem cells (ESCs) are derived from the inner cell
mass of mammalian blastocysts [1, 2]. Because of their ability to
proliferate indefinitely in vitro while maintaining an undiffer-
entiated state and their developmental potential to differentiate
into most cell types [3–8], ESCs are useful not only for ana-
lyzing critical steps of cell development but also as a potential
source for cell replacement therapy.
A target for such an application is Parkinson’s disease (PD)
because it primarily involves the degenerative loss of a specific
cell type, namely the midbrain dopaminergic (DA) neurons in
the substantia nigra [9, 10]. Several laboratories have demon-
strated that phenotypes characteristic of midbrain DA neurons
can be efficiently induced in vitro and/or in vivo from mouse
and primate ESCs. The five-stage method is a successful in vitro
induction procedure in which mouse ESCs (mESCs) are first
grown to form embryoid bodies (EBs), followed by selection
and expansion of Nestin neural precursors and differentiation
into neural subtypes [11]. This method can generate as much as
34% of tyrosine hydroxylase (TH) cells among Tuj1 neurons
in the presence of signaling molecules such as sonic hedgehog
(Shh), fibroblast growth factor 8 (FGF8), and ascorbic acid [11].
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Another efficient in vitro method for DA neuron induction is the
coculture method with PA6 feeder cells that have stromal cell–
derived inducing activity (SDIA) [12]. This procedure also
efficiently induces a high proportion of TH neurons (30% of
Tuj1 neurons) from mESCs. The coculture method offers
additional advantages over EB-based methods, such as (a) it
does not depend on EB formation and selection of neural pre-
cursors, (b) the whole procedure takes approximately half the
amount of time as the five-stage method, and (c) it showed
reduced variability and generally higher yield of TH neurons
when multiple ESCs were tested and compared with each other
[13]. Importantly, this stromal cell coculture method was suc-
cessfully applied for efficient generation of TH neurons from
primate ESCs [14], suggesting that ESCs from different species,
including human, may be coaxed to differentiate into DA neu-
rons using this procedure. Indeed, several laboratories very
recently reported initial results that human ESCs (hESCs) can
differentiate into DA neurons in vitro using the stromal cell
coculture method [15–17].
It is possible to successfully facilitate the differentiation of
ESCs to certain lineages by genetic manipulation consisting of the
specific activation of key fate-determining transcription factors [18,
19]. Recent data from this and other groups demonstrated that
forced expression of Nurr1, a transcription factor critical for the
development of midbrain DA neurons [20–22], can greatly facili-
tate the induction of DA neurons from mESCs [23, 24]. Our
findings showed that Nurr1 transduction in ESCs resulted in an
approximately fivefold increase in the proportion of DA neurons
[24]. Nurr1 overexpression led to upregulation of midbrain DA
markers such as TH, aromatic L-amino acid decarboxylase
(AADC), and dopamine transporter (DAT) and showed increased
DA release in response to membrane depolarization. It is likely that
genetic modification of ESCs combined with optimal culture con-
ditions using extrinsic factors could result in efficient induction of
certain cell lineage(s). Indeed, it was demonstrated that Nurr1-
overexpressing mESCs, treated with signaling molecules (Shh,
FGF8, and ascorbic acid), differentiated into DA neurons with a
high efficiency (62%–78% of TH/Tuj1 neurons) [23, 24]. In
addition to ESCs, the role of Nurr1 was investigated in neural
precursor cells such as adult hippocampal precursor cells [25],
cerebellum-derived immortalized cells, C17.2 [26], and in vitro
expanded central nervous system presursor cells [27]. Whereas all
these studies showed the potent ability of Nurr1 to induce the DA
phenotype (typically TH expression), the maturity and function of
the resulting DA cells were variable, suggesting that additional
transcription factors and/or signaling molecules are necessary.
At present it is not known whether Nurr1 overexpression and
PA6 coculture may co-operatively facilitate the differentiation of
ESCs into DA neurons. Whereas SDIA is known to accumulate on
the surface of PA6 stromal cells, its molecular nature is not known
[12, 14]. If SDIA shares a close relationship with the Nurr1 path-
way, it may not have a synergistic effect on DA neuron induction
using the Nurr1 overexpression and PA6 coculture method. Fur-
thermore, questions remain about the synergistic effect of combin-
ing signaling molecules such as Shh and FGF8 with SDIA on the
induction of DA neuronal phenotype. Our work centered on two
main objectives: (a) to address questions about the combined roles
of SDIA, signaling molecules, and Nurr1 on neurogenesis and/or
DA neuron differentiation from ESCs; and (b) to establish an
effective and reliable protocol for in vitro ESC differentiation to
generate DA neurons suitable for transplantation. Toward these
goals, we studied the in vitro behavior of Nurr1-overexpressing
mESCs in the PA6 coculture method and the effect of signaling
molecules on their differentiation. Through systematic analyses, we
observed that a very high proportion of midbrain DA neurons (up
to 90% of Tuj1 neurons) can be generated from Nurr1-overex-
pressing mESCs using the optimized PA6 coculture method within
a short period of time (14 days). Furthermore, transplantation
studies using the resulting DA neurons demonstrate that they can
stably integrate into the host striatum and express the DA pheno-
type.
MATERIALS AND METHODS
In Vitro Differentiation of ESCs
PA6 cells were purchased from Riken (Tsukuba, Japan, http://
www.riken.go.jp/engn) and were maintained in PA6 culture
medium –minimum essential medium (Gibco, Rockville, MD,
http://www.invitrogen.com) supplemented with 50 U/ml peni-
cillin and 50 g/ml streptomycin (PEST) (Gibco), and 10% fetal
bovine serum (HyClone, Logan, UT, http://www.hyclone.com)
[12]. Undifferentiated mESCs (the wild-type D3 and Nurr1-
expressing N2 or N5 cells [24]) were maintained on gelatin-
coated dishes in Dulbecco’s modified minimal essential medium
(Gibco) supplemented with 2 mM glutamine (Gibco), 0.001%
-mercaptoethanol (Gibco), 1 nonessential amino acids
(Gibco), 10% donor horse serum (Sigma, St. Louis, http://
www.sigmaaldrich.com), and 2,000 U/ml human recombinant
leukemia inhibitory factor (R&D Systems Inc., Minneapolis,
http://www.rndsystems.com). To differentiate ESCs in vitro,
PA6 cells were plated on gelatin-coated culture dishes to make
a uniform feeder monolayer 1 day before the addition of D3, N2,
or N5 cells, and then ESCs were added at a density of 1  103
per well of a 24-well plate. Embryonic stem differentiation
medium I (Glasgow minimum essential medium [G-MEM]
[Gibco] supplemented with 10% knockout serum replacement
[Gibco], 0.1 mM nonessential amino acids [Gibco], 1 mM
sodium pyruvate [Sigma], 0.1 mM 2-mercaptoethanol [Gibco],
and PEST [Gibco]) was used for 8 days and then replaced with
embryonic stem differentiation medium II (equivalent to N-2
medium in other paper [12]) (G-MEM [Gibco] supplemented
with N-2 supplement [Gibco], 0.1 mM nonessential amino acids
[Gibco], 1 mM sodium pyruvate [Sigma], 0.1 mM 2-mercapto-
ethanol [Gibco], and PEST [Gibco]) for an additional 6 days
[12]. The culture medium was changed on day 4 and every other
day thereafter.
Analyses of Dopamine
HPLC analyses of dopamine were performed after 24 hours of
conditioning at day 14. The proteins from 0.2 ml of media from
each well of a 12-well plate were precipitated by adding per-
chloric acid (PCA) and EDTA at final concentrations of 0.33 M
and 0.17 mM, respectively. After aspiration of the residual
media (0.6 ml), the cells were treated with 0.2 ml of 50 mM KCl
in embryonic stem differentiation medium II for 30 minutes at
37°C. Then the media were collected, and the proteins were
precipitated by the addition of PCA and EDTA as described
above. The mixture was centrifuged at 4°C for 10 minutes at
14,000g, and the supernatant was used for HPLC analysis. Cells
were allowed a 1-day recovery in fresh medium after which time
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they were washed, scraped, collected, and vortexed in a chilled
(4°C) 0.24 ml solution of 0.33 M PCA and 0.17 mM EDTA.
After centrifugation at 14,000g for 10 minutes, intracellular
fraction (supernatant) and cell pellet were separated for in-
tracellular DA and protein analysis (data not shown), respec-
tively. Samples were analyzed as described previously [24].
Briefly, samples were applied to reverse-phase HPLC using a
Velosep RP-18 column (100  3.2 mm) and a Coulochem
II® electrochemical detector equipped with a 5014 analytical
cell (ESA Biosciences, Inc., Chelmsford, MA, http://www.
esainc.com). The flow rate of the mobile phase (0.1 M
sodium phosphate buffer [pH 2.65], 0.1 mM EDTA, 0.4 mM
sodium octyl sulphate, and 9% methanol) was 0.8 ml/minute.
The potentials of the guard cell and the first and the second
electrodes in the analytical cell were set at 330, 0, and 310
mV, respectively. Dopamine was identified by retention time
and quantified based on peak height using the EZChrom
Chromatography Data System.
Immunostaining
After 14 days of differentiation on PA6 feeder layer, ESCs were
fixed with 4% formaldehyde (Electron Microscopy Sciences,
Hatfield, PA, http://www.emsdiasum.com) for 30 minutes,
rinsed with phosphate-buffered saline (PBS), and then incubated
with blocking buffer (PBS, 10% normal donkey serum [NDS] or
normal goat serum [NGS], and 0.1% Triton X-100) for 10
minutes. Cells were incubated overnight at 4°C with primary
antibodies diluted in PBS containing 2% NDS or NGS. The
following primary antibodies were used: rabbit anti–-tubulin
(1:2,000; Covance, Richmond, CA, http://www.covance.com),
sheep anti-TH (1:200; Pel-Freez, Rogers, AK, http://www.pel-
freez.com), sheep anti-AADC (1:200; Chemicon, Temecula,
CA, http://www.chemicon.com), rat anti-DAT (1:1,000; Chemi-
con), rabbit anti–5-hydroxytryptamine (HT) (1:3,000; DiaSorin,
Stillwater, MN, http://www.diasorin.com), and rabbit anti--
aminobutyric acid (GABA) (1:5,000; Sigma). The coverslips
were washed with PBS and then incubated with fluorescent-
labeled secondary antibodies [Alexa Fluor 488 (green) or Alexa
Fluor 568 (red)-labeled donkey/goat IgG (1:500; Molecular
Probes, Invitrogen, Carlsbad, CA, http://www.invitrogen.com)]
in PBS with 2% NDS or NGS for 30 minutes at room temper-
ature. The coverslips were rinsed for 3 10 minutes in PBS and
mounted onto slides using Gel/Mount (Biomeda Corp., Foster
City, CA, http://www.biomeda.com). Cells were examined us-
ing a Leica TCS/NT confocal microscope equipped with kryp-
ton, krypton/argon, and helium lasers. Cells were counted ac-
cording to the protocol that our laboratory set up previously [24]
with a slight modification. We skipped fields where we could
not find any cells.
Semiquantitative Reverse Transcription– and Real-
Time Polymerase Chain Reaction Analyses
After differentiation, total RNA from ESC-derived neurons was
prepared using TriReagent (Sigma) followed by treatment with
DNase I (Ambion, Austin, TX, http://www.ambion.com).
cDNA was obtained using 5 g of RNA with the SuperScriptTM
first-strand synthesis system for reverse transcription–polymer-
ase chain reaction (RT-PCR) (Invitrogen). The resulting cDNA
was used as a template for the PCR reactions. To reduce the
nonspecific signals, primers of each gene were designed using
the MacVector software (Accelrys, San Diego, CA, http://www.
accelrys.com). We selected primer sets that yielded specific
products without the presence of nonspecific bands as evaluated
by gel electrophoresis. The following primer sets were chosen
for semiquantitative RT- and real-time PCR analyses.
Actin: 5-GGCATTGTGATGGACTCCGG-3; 5-TGCCA-
CAGGATTCCATACCC-3 (358 bp)
TH: 5-TTGGCTGACCGCACATTTG-3; 5-ACGAGAG-
GCATAGTTCCTGAGC-3 (336 bp)
AADC: 5-CCTACTGGCTGCTCGGACTAA-3; 5-GCG-
TACCAGGGACTCAAACTC-3 (715 bp)
DAT: 5-CAGAGAGGTGGAGCTCATC-3; 5-GGCA-
GATCTTCCAGACACC-3 (328 bp)
Pitx3: 5-CTCTCTGAAGAAGAAGCAGCG-3; 5-CCG-
AGGGCACCATGGAGGCAGC-3 (491 bp)
Aldehyde dehydrogenase 2 (AHD2): 5-CATTGAGAGT-
GGGAAGAAAGAAGG-3; 5-AGTGAAGAGTCCTGCTGC-
TAAACC-3 (232 bp)
Calbindin: 5-GCAGTCATCTCTGATCACAGC-3; 5-G-
AGGTCTGTGTACTCTGCTAG-3 (428 bp)
Girk2: 5-CCTTGTCTCCCATTTCCTTCTTTTC-3; 5-C-
TGTCTGCTTGTCCCATCTGAAC-3 (147 bp)
Tryptophan hydroxylase (TPH): 5-CTACACTCCAGAGC-
CAGACAC-3; 5-GACATCAAGGTCATACCGCAAC-3 (501
bp)
Glutamic acid decarboxylase (GAD): 5-GGGTTTGAG-
GCACACATTGATAAG-3; 5-GCGGAAGAAGTTGACCT-
TGTCC-3 (279 bp)
Choline acetyltransferase (ChAT): 5-GCCAATCCATTC-
CCACTGAC-3; 5-CATCCAAGACAAAGAACTGG-3 (198
bp).
For semiquantitative RT-PCR, PCR reactions were carried out
with 1 IN Reaction Buffer (Epicentre Technologies, Madison,
WI, http://www.epicentretechnology.com), 1.4 nM of each primer,
and 2.5 units of Taq I DNA polymerase (Promega, Madison, WI,
http://www.promega.com). Samples were amplified in an Eppen-
dorf Thermocycler (Brinkmann Instruments, Westbury, NY, http://
www.brinkmann.com) under the following conditions: denaturing
step at 95°C for 40 seconds, annealing step at 60°C for 30 seconds,
and amplification step at 72°C for 1 minute for 20–35 cycles.
cDNA templates were normalized based on the actin-specific sig-
nal, and PCR cycling was adjusted in such a way that each primer
set amplified its corresponding gene product at its detection thresh-
old to avoid saturation effects.
We performed real-time PCR to quantify expression levels.
The amplifications were performed in 25-l volumes containing
0.5 m of each primer, 0.5 X SYBR Green I (Molecular Probes
Inc., Eugene, OR, http://probes.invitrogen.com), and 2 l of
10-fold diluted cDNA using the DNA engine Opticon (MJ
Research, Waltham, MA, http://www.mjr.com). The PCR reac-
tions consisted of 50 cycles using the following temperature
profile: 95°C for 30 seconds, 60°C for 30 seconds, 72°C for 30
seconds, and 79°C for 5 seconds. The melting temperature (Tm)
of each PCR product was determined and turned out to be more
than 79°C. After each PCR cycle, the fluorescent signals were
detected at 79°C to melt primer dimers (Tm of all primer dimers
used in this study was 79°C). The purity of each PCR product
(defined as the presence of a single, specific band) was con-
firmed by gel electrophoresis. A standard curve was constructed
using GAPDH (glyceraldehyde 3-phosphate dehydrogenase)
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plasmid DNA (from 102 to 107 molecules). The fluorescent
signals from specific PCR products were normalized against
that of the actin gene, and then relative values for N2 cells were
calculated by setting the normalized value of D3 cells as one for
each gene. Two independent samples were analyzed for each
gene, and all the reactions were repeated more than twice.
Electrophysiological Experiment
Differentiated ESCs were examined using the whole-cell re-
cording configuration of the conventional ‘dialyzed’ whole-cell
patch-clamp technique. Differentiated cells were obtained by
seeding ESCs onto 12-mm round coverslips and culturing for 14
days. Patch electrodes were fabricated from a borosilicate glass
capillary (Sutter Instrument Company, San Rafael, CA, http://
www.sutter.com) by using a vertical micropipette puller (Nar-
ishige, Tokyo, http://www.narishige.co.jp). The patch electrodes
were fire-polished on a microforge (Narishige) and had resis-
tances of 1–3 M when filled with the internal solution de-
scribed below. The cell membrane capacitance and series resis-
tance were compensated (typically 80%) electronically using
a patch-clamp amplifier (Axopatch-200A; Axon Instruments/
Molecular Devices Corp., Union City, CA, http://www.molecu-
lardevices.com). Current protocol generation and data acquisi-
tion were performed using pClamp 8.0 software on an IBM
computer equipped with an analogue-to-digital converter (Digidata
1322A; Axon Instruments/Molecular Devices Corp.). Voltage
traces were filtered at 2 kHz by using the four-pole bessel filter in
the clamp amplifier and stored on the computer hard drive for later
analysis. All experiments were performed at room temperature
(21°C–24°C). For recording of membrane potential in current
clamp mode, the patch pipette solution contained (in mM): KCl
134, MgCl2 1.2, MgATP 1, Na2GTP 0.1, EGTA 10, glucose 14,
and HEPES 10.5 (pH adjusted to 7.2 with KOH). The bath solution
contained (in mM): NaCl 126, KCl 5, CaCl2 2, MgCl2 1.2, glucose
14, and HEPES 10.5 (pH adjusted to 7.4 with NaOH).
Transplantation Analysis
D3 and N2 ESC colonies were isolated from PA6 feeder layer at
differentiation day 9 by incubation with 2.5 ml of papain solu-
tion (Papain Dissociation Kit, Worthington Biochemical Corpo-
ration, Freehold, NJ, http://www.worthington-biochem.com) for
5 minutes at 37°C. The dissociated colonies were transferred to
a 15-ml tube and then incubated for an additional 5 minutes at
37°C followed by gentle trituration using a 1-ml tip and a 5-ml
pipette. The cells were suspended at a density of 50,000 cells per
l. One microliter of the cell suspension was grafted into the
right striatum (from the bregma: AP 0.05, L –0.18, V –0.30,
IB 9) of C57/BL/6 mice (n  10) (Charles River Laboratories,
Wilmington, MA, http://www.criver.com). Prior to surgery,
mice received an i.p. injection of preanesthesia (acepromazine
[3.3 mg/kg, PromAce; Fort Dodge Laboratories, Inc., Fort
Dodge, IA]) and atropine sulfate (0.2 mg/kg; Phoenix Pharma-
ceuticals, Belmont, CA, http://www.phoenixpeptide.com) fol-
lowed by an i.p. injection of ketamine (60 mg/kg; Fort Dodge
Laboratories, Inc.) and xylazine (3 mg/kg; Phoenix Pharmaceu-
ticals). Transplantation was performed using a 22-gauge needle,
10-l syringe (Hamilton, Reno, NV, http://www.hamiltoncomp.
com), and a Kopf stereotaxic frame (David Kopf Instruments,
Tujunga, CA, http://www.kopfinstruments.com). An s.c. injec-
tion of buprenorphine (0.032 mg/kg; Sigma) was given as post-
operative anesthesia. Four weeks after transplantation, the mice
were terminally anesthetized with an i.p. overdose of pentobar-
bital (150 mg/kg; Sigma). The mice were perfused intracardially
with 100 ml of heparin saline (0.1% heparin in 0.9% saline)
followed by 200 ml of paraformaldehyde (4% in PBS). The
brains were postfixed for 8 hours in the same solution and then
equilibrated in sucrose (20% in PBS), sectioned at 40 m on a
freezing microtome, and collected in PBS. For histological
analyses, the sections were stained with antibodies against TH
and neuronal nuclei (NeuN). Nissl staining was performed as
described previously [28]. Cells were counted from blind-coded
samples using an integrated Axioskop 2 microscope (Carl Zeiss,
Thornwood, NY, http://www.zeiss.com) and StereoInvestigator
image capture equipment and software (MBF Bioscience, Wil-
liston, VT, http://www.microbrightfield.com).
RESULTS
Nurr1 Overexpression Promotes the Neuronal
Differentiation of ESCs When Cocultured with PA6
Feeder Cells
Using the five-stage in vitro differentiation method, it has been
shown that exogenous expression of Nurr1 and treatment of
signaling molecules (Shh, FGF8, and ascorbic acid) can syner-
gistically increase the induction of DA neurons [23, 24]. To
address whether Nurr1 overexpression and/or signaling mole-
cules can induce DA neurons in the presence of SDIA, we
differentiated D3 and Nurr1-expressing N2 and N5 ESCs on the
PA6 feeder layer for 8 days in embryonic stem differentiation
medium I and then for an additional 6 days in embryonic stem
differentiation medium II (see ‘Materials and Methods’). Con-
sistent with our previous results [24], Nurr1 expression was
persistently maintained throughout differentiation. Nurr1 ex-
pression was detected only in N2 cells, but not in D3 at the
beginning of the experiment, and was approximately sixfold
higher in N2-derived cells compared with D3-derived cells at a
final stage (Fig. 1B). During this procedure, ESCs were treated
with signaling molecules such as Shh, FGF8, and ascorbic acid
at different time periods (Fig. 1A). Under all three conditions for
D3 cells, the numbers of Tuj1 cells generated after 14 days in
vitro differentiation were not significantly different from each
other (Fig. 1C). This is in general agreement with a previous
report that treatment with diverse signaling molecules, including
Shh and FGF8, did not promote neural differentiation of ESCs
on the PA6 feeder layer [12]. In contrast, the number of N2-
derived neurons was significantly higher (twofold; p  .05)
than that of D3 cells although the same number of ESCs was
initially used in each condition (Fig. 1C). N2 cells under con-
dition II [N2SM (II)] generated a slight, but statistically sig-
nificant (p  .05), increase of TuJ1 cells, compared with
D3SM (II) or D3SM (III). In addition, these TuJ1 cells
represented approximately 37%, 58%, and 62% of total cell
numbers in D3, N2, and N2SM (II), respectively (data not
shown). Consistent with these results, our real-time PCR anal-
yses showed that the level of -tubulin mRNA normalized to
actin mRNA increased approximately 2.5-fold in N2SM (II)
cells, compared with D3 cells (data not shown). Another Nurr1-
expressing ESC clone, N5, showed the same result as the
N2 (data not shown). Taken together, Nurr1 overexpression
promoted the neuronal differentiation of ESCs. When 4,6-
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diamidino-2-phenylindole (DAPI) cells were counted in 10
fields, the number of DAPI cells was slightly higher (by
30%–40%) in N2 cells than D3 cells, suggesting that Nurr1 may
also have a modest effect on cell survival in our culture protocol.
Nurr1 Overexpression and Signaling Molecules
Synergistically Facilitate the Differentiation of
ESCs to the DA Fate When Cocultured with PA6
Feeder Cells
The expression of the DA phenotype amongst Tuj1 neurons
was analyzed next. As shown in Figure 1D, approximately 28%
of -tubulin neurons were TH in naı¨ve D3 cells after the
whole 14-day procedure. When signaling molecules were added
to the D3 cells, the proportions of TH neurons among total
neurons were not significantly changed (30%–33% depending
on treatment conditions). When N2 ESCs were differentiated on
the PA6 feeder cells, a much higher proportion of Tuj1 neu-
rons was TH (55%; p  .05; Fig. 1D), demonstrating that
Nurr1 and SDIA may cooperatively induce the DA phenotype.
Furthermore, when treated with the signaling molecules, a much
greater effect was observed with statistical significance (p 
.05), and approximately 90% of Tuj1 neurons were TH under
Figure 1. Synergistic effects of Nurr1, signaling molecules, and SDIA on efficient generation of TH neurons. (A): A schematic diagram for in vitro
differentiation of ESCs on PA6 feeder layer. PA6 cells were plated on gelatin-coated culture dish and incubated overnight to make a confluent uniform
feeder monolayer. The next day (day 0), the PA6 feeder monolayer was washed with embryonic stem differentiation medium, and D3 and N2 cells
were added to initiate differentiation. ESCs were allowed to differentiate on the PA6 feeder cells for 14 days. During that differentiation period,
signaling molecules such as Shh, FGF8, and ascorbic acid were added at different time intervals as follows: condition I, treatment with Shh and FGF8
during days 7–9 and ascorbic acid treatment during days 9–14; condition II, treatment with Shh and FGF8 during days 5–9 and ascorbic acid treatment
during days 9–14; condition III, treatment with Shh and FGF8 during days 7–11 and ascorbic acid treatment during days 11–14. (B): Nurr1 expression
during in vitro differentiation of D3 and N2 ESCs. Nurr1 gene expression was examined at day 0, 7, and 14 during in vitro differentiation of D3 and
N2 ESCs by semiquantitative reverse transcription–polymerase chain reaction analysis. (C): Effect of transgene expression of Nurr1 on neurogenesis.
-tubulin neurons derived from ESCs were detected by staining with anti-Tuj1 antibodies. Positive cells were counted in 10 random fields per
sample. Each group represents an average of three samples from independent experiments. Fisher’s PLSD post hoc analysis was performed with a
significance level of 0.05. *p  .05 compared with D3 and D3SM (I); #p  .05 compared with D3SM (II) and D3SM (III). (D): Exogenous
expression of Nurr1 under condition II [N2SM (II)] results in a significantly high proportion (90%) of TH neurons among total neurons.
ESC-derived neurons were stained with anti-TH and anti-Tuj1 antibodies. -tubulin and TH cells were counted in 10 random fields per sample.
Cell densities of TH neurons were calculated by dividing the numbers of TH cells by those of -tubulin cells. Each group represents an average
of three samples from independent experiments. Fisher’s PLSD post hoc analysis was performed with a significance level of 0.05. *p .05 compared
with D3; #p .05 compared with N2. Abbreviations: AA, ascorbic acid; D3, naı¨ve embryonic stem cells; ESC, embryonic stem cell; FGF8, fibroblast
growth factor 8; I, condition I; II, condition II; III, condition III; N2, Nurr1-expressing embryonic stem cell line; PLSD, protected least-significant
difference; Shh, sonic hedgehog; SM, signaling molecule; TH, tyrosine hydroxylase.
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the optimal condition II (Figs. 1D, 2A). We did not test the
effect of individual signaling molecules in this experiment.
However, the previous report indicates that each signaling mol-
ecule has a marginal effect on the differentiation into DA
neurons and a much greater effect when treated in combination
[11]. Another Nurr1-expressing ESC clone, N5, was able to
generate a similarly high proportion of TH/Tuj1 neurons
under the same optimal condition II (data not shown).
TH Neurons Coexpress the Other Midbrain
DA Markers
TH cells exist in many neuronal phenotypes, including DA and
noradrenergic (NA) neurons. Therefore, we determined whether
TH neurons generated by the optimized in vitro condition II
have the midbrain DA neuron phenotype. The in vitro differen-
tiated N2 cells under condition II were costained using antibod-
ies against TH, AADC, DAT, -aminobutyric acid (GABA),
and 5-HT. AADC is an enzyme that is involved in the last step
of dopamine and serotonin biosynthesis [29]. As shown in
Figure 2B, all TH neurons were AADC but some of the
AADC cells were TH	. Thus, these TH	/AADC cells may
represent serotonergic neurons. Some of the TH cells were
DAT, indicating that these neurons have acquired a mature DA
phenotype. Notably, these TH cells did not express GABA,
suggesting that they have the midbrain, but not olfactory, DA
neuronal phenotype. These TH neurons also did not coexpress
5-HT. To investigate mRNA expression of midbrain DA neu-
ron-specific markers, semiquantitative RT- and quantitative real-
time PCR analyses were carried out for D3 and N2 clones after
14 days of differentiation on the PA6 feeder layer (Figs. 3A,
3B). The effect of signaling molecules was studied in N2 cells
using our optimized condition [SM (II)] and compared with D3
cells in the absence and presence of signaling molecules. We
first designed several primer sets for each gene using the
MacVector software. Primer sets that can produce a specific
band without nonspecific products were screened using cDNA
prepared from total RNA. Using these primers, the expression
level of each gene was examined and normalized to the house-
keeping gene actin. Our results of semiquantitative RT-PCR
(Fig. 3A) were very consistent with those of real-time PCR
(Figs. 3B, 3C). Expression of TH mRNA was increased approx-
imately sevenfold in N2SM (II), compared with D3 cells
(Figs. 3A, 3B). This is consistent with the increase of the
TH/Tuj1 population from 28% to 90% (Fig. 1D). Additional
DA markers such as DAT, AADC, and Girk 2 were also
dramatically upregulated (15-fold). High expression of Girk 2,
an A9-preferential DA neuronal marker [30–33], indicates that
certain feature(s) of the A9 DA phenotype may be induced
under these conditions. However, the expression of another
midbrain maker, AHD2 [34], was marginally increased. Other
DA markers, like calbindin and Pitx3, were also nonsignifi-
cantly upregulated (Fig. 3B).
We next examined gene regulation of various other neu-
rotransmitter markers (Fig. 3C). Expression of NA marker,
dopamine -hydroxylase, was not detected in either D3 or N2
clones (data not shown). Therefore, these TH cells exhibit
the DA, not the NA, phenotype. In contrast to the upregula-
tion of DA marker genes, the expression of the GABAergic
and cholinergic (GAD and ChAT, respectively) was only
minimally changed. Thus, Nurr1 overexpression and signal-
ing molecules seem to specifically facilitate the differentia-
tion of ESCs to the DA fate when cocultured with PA6 feeder
cells. In support of this, real-time PCR analysis demonstrated
that the DA-specific markers are specifically upregulated in
the N5 clone as well (data not shown). However, the expres-
sion of a serotonergic neuronal marker, TPH, was upregu-
lated by approximately 2.5-fold.
In Vitro Differentiated Cells Exhibit Active
Membrane Properties Characteristic of DA Neurons
The electrophysiological properties of neurons differentiated
from N2SM (II) cells were investigated using the conven-
tional “dialyzed” whole-cell recording technique. The resting
membrane potentials of the differentiated neurons ranged
from – 48 to –57 mV (average, 	55.3 
 2.3 mV). Recordings
in the current-clamp configuration allowed us to determine
the active membrane characteristics of these neurons. Pro-
longed depolarizing current injections (Fig. 4A) demon-
strated the capability to fire fast action potentials and action
potential series (action potential amplitude ranging from 32
to 47 mV [average, 41 
 3.5 mV], action potential half width
ranging from 1.4 to 3.7 ms [average, 2.2 
 0.3 ms]). The
neurons also exhibited voltage-dependent membrane currents
(Fig. 4B). Depolarizing voltage steps elicited both large
outward potassium currents (653 
 134 pA) and fast inward
Na current (350 
 76 pA). These results indicate that the
differentiated cells have characteristics of neurons. In addi-
tion, the changes of membrane potential were investigated in
the neurons subjected to hyperpolarizing current injections
(Fig. 4C). As the intensity of the hyperpolarizing current was
increased, there was a time-dependent reduction in the mem-
brane deflection, indicating an anomalous rectification that is
a characteristic of midbrain DA neurons [35, 36]. These
Figure 2. TH neurons generated by N2 cells under condition II
coexpress other markers specific for midbrain DA neurons. (A): Detec-
tion of -tubulin and TH cells by immunocytochemistry in differen-
tiated D3 and N2 [N2SM (II)] cells. (B): TH neurons coexpress
midbrain DA markers such as AADC and DAT, but not GABA and
5-HT. Embryonic stem cell–derived neurons were stained with anti-TH,
anti-AADC (dopaminergic, serotonergic), anti-DAT (dopaminergic),
anti-GABA (GABAergic), and anti–5-HT (serotonergic) antibodies. Ab-
breviations: AADC, aromatic L-amino acid decarboxylase; DA, dopa-
minergic; DAT, dopamine transporter; GABA, -aminobutyric acid;
HT, hydroxytryptamine; SM, signaling molecule; TH, tyrosine hydrox-
ylase.
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time-dependent inward rectifications were observed in five out
of seven cells tested, indicating that a majority of the neurons
have the electrophysiological property of DA neurons.
Nurr1 Overexpression and Signaling Molecules
Greatly Facilitate the Production and Release of DA
on PA6 Feeder Cells
An important physiological aspect of in vitro differentiated DA
neurons is their ability to produce and release DA in response to
membrane depolarization. To test this, ESCs were differentiated
for 14 days under our optimized conditions and analyzed for the
production and release of DA. The 24 hour–conditioned media
were prepared at day 14, and then cells were treated with 50 mM
KCl. After a 1-day recovery in fresh medium, cells were har-
vested and intracellular DA levels were measured as described
in the Materials and Methods section. For these samples, DA
levels were assayed by reverse-phase HPLC and expressed as pg
per 20 l medium/solution. As shown in Figure 5, DA released
into conditioned media and in response to membrane depolar-
ization were 15- and four fold higher in N2SM (II) (48 pg/20
l and 24 pg/20 l, respectively) than in D3 cells (3.25 pg/20 l
and 5.75 pg/20 l, respectively). The intracellular DA level was
also 18-fold higher in N2SM (II) cells (99.5 pg/20 l) com-
pared with that in D3 cells (5.5 pg/20 l).
Efficient In Vivo Integration and Generation of
TH Neurons after Implantation of N2 Cells
Differentiated under Condition II into the
Mouse Striatum
The in vitro data above indicate that the combined condition
of Nurr1, signaling molecules, and SDIA may provide an
optimal method for efficiently generating midbrain DA neu-
rons for the future cell transplantation therapy to treat PD.
Toward this long-term goal, we next investigated whether
ESCs differentiated under this condition could efficiently
integrate or generate TH neurons after implantation. Mori-
zane et al., using naı¨ve ESCs, grafted cells that had been
cultured on PA6 for 12 days [37]. When the cells were
grafted as individual cell suspensions into mouse striatum on
day 12, the number of surviving cells was much lower than
when the cells were grafted as nondissociated cell clumps.
This may be due to damage to the neurites when the cells are
dissociated prior to transplantation. Because cell suspension
has the advantage of quantification and reproducibility of
grafting conditions, we retested the transplantation condition
for individual cell suspension. First, we examined when the
ESCs enter the postmitotic phase during differentiation (Fig.
6A). After differentiation for 7–10 days, ESC colonies were
all isolated from the feeder layers by treatment with papain
for 5 minutes at 37°C, dissociated into a single cell suspen-
sion in 5 ml medium, and counted. As shown in Figure 5A,
ESCs stopped growing after 8 –9 days. N2 cells entered
postmitotic phase 1 day sooner than D3 cells, indicating
earlier neuronal maturation. Next, we examined cell viability
after isolation by papain digestion (Fig. 6B). Cells were
isolated from feeder layers after 7–10 days of differentiation,
replated onto poly-L-ornithine/fibronectin plates, and then
counted for cell viability after 12 hours. The viability of D3
cells decreased after 9 days of induction. This compares
favorably with N2 cells whose viability started to decrease at
day 7 and even more after the ninth day. Finally, TH cell
number was examined during differentiation (Fig. 6C). The
number of TH cells in D3 cells showed a mild increase
through differentiation, whereas a dramatic increase in N2
cells was observed after 9 days of incubation under condition
II. Based on these observations, we transplanted ESCs after 9
Figure 3. Semiquantitative RT- and real-time PCR analyses for DA neuron markers and other neurotransmitter markers. Semiquantitative RT- (A)
and real-time PCR analyses (B, C) of midbrain DA markers (A, B) and neurotransmitter markers (A, C) after in vitro differentiation of naı¨ve D3,
D3SM(II), N2, and N2SM(II) conditions. The expression levels of each gene were normalized to that of actin. Similar patterns were obtained when
we used another gene, GAPDH, for normalization (data not shown). In (B, C), relative expression levels of each gene were determined in relation
to those from naı¨ve D3 cells. Each group represents an average of two samples from independent experiments. Fisher’s PLSD post hoc analysis was
performed with a significance level of 0.05. *p  .05 compared with D3. Abbreviations: AADC, aromatic L-amino acid decarboxylase; AHD2,
aldehyde dehydrogenase 2; ChAT, choline acetyltransferase; DA, dopaminergic; DAT, dopamine transporter; GABA, -aminobutyric acid; GAPDH,
glyceraldehyde 3-phosphate dehydrogenase; HT, hydroxytryptamine; PCR, polymerase chain reaction; PLSD, protected least-significant difference;
RT, reverse transcription; SM, signaling molecule; TH, tyrosine hydroxylase; TPH, tryptophan hydroxylase.
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days of differentiation, when those parameters (i.e., total cell
number, survival, and TH cell numbers) are suboptimal.
Four weeks after transplantation, the recipient mice were
sacrificed, fixed by perfusion, and then analyzed for in vivo
generation and integration of TH neurons. In a graft of N2
cells differentiated under condition II, we could see many
TH cell bodies (Figs. 7C, 7D). In contrast, few TH cell
bodies were detected in control grafts of D3 cells (Figs. 7A,
7B). When we counted the total number of TH cells per
graft area (mm3) by staining for TH/Nissl, we found an
average of 312 neurons for N2 cells under condition II and 28
for the naı¨ve D3 cells (Fig. 7E). Costaining with antibodies
against TH and NeuN (Figs. 7F–7K) was consistent with the
TH/Nissl results, showing a much higher number of TH
cells with N2 cells (Fig. 7J) than with D3 cells (Fig. 7G).
These results indicate that TH cells derived from N2 cells
under condition II are more efficiently generated and main-
tained in vivo.
DISCUSSION
In this study, we showed that coculturing Nurr1-overexpressing
ESCs (N2 or N5) with PA6 stromal feeder cells leads to the
generation of a high proportion of TH neurons (55% of
Tuj1 neurons; Fig. 1D). Surprisingly, when N2 cells were
treated with Shh and FGF8 during days 5–9 followed by ascor-
bic acid treatment, the proportion of TH neurons was further
enhanced up to 90% of Tuj1 neurons, whereas naı¨ve D3
cells did not show any cooperative effect with signaling mole-
cules on the PA6 stromal cell feeder layer. Importantly, these
ESC-derived TH neurons were found to coexpress AADC and
DAT, but not GABA or 5-HT (Fig. 2B), suggesting that they
have the midbrain DA neuronal phenotype.
Lee et al. [11] showed in a five-stage protocol that treatment
with the signaling molecules during expansion of neural precur-
sors followed by treatment with ascorbic acid during the differ-
entiation phase (stage 5) is most effective for inducing TH DA
neurons from mESCs. Using the same method, it has recently
been shown that exogenous expression of Nurr1 in mESCs can
significantly enhance the generation of TH neurons among
Tuj1 cells (three- to fivefold depending on ESC clones [23,
24]). Thus, it appears that Nurr1 overexpression similarly en-
hances the induction of TH neurons in both the five-stage and
PA6 coculture procedures. However, the present study reveals
several salient features of different in vitro differentiation meth-
ods for DA neuron differentiation. First, we found that there was
a significant increase (approximately twofold) in the number of
-tubulin cells generated from N2 cells in the PA6 coculture
method (Fig. 1C), but not in the five-stage method [24]. Given
that the PA6 coculture directly induces neuronal cells from
ESCs whereas the five-stage method is based on selection of
neural precursor cells [11, 14], the twofold increase of -tubu-
lin neuronal cells only in the PA6 method is a significant one.
Consistent with this finding, the mRNA level of -tubulin was
upregulated approximately 2.5-fold in the N2SM (II) condi-
tion compared with D3 cell–derived cells (data not shown).
Thus, it appears that Nurr1 and unidentified molecule(s) in the
PA6 coculture (e.g., SDIA) may cooperatively enhance the
generation of neurons. In this context, it is noteworthy that
Nurr1 has been shown to induce cell cycle arrest and a highly
differentiated cell morphology in dopaminergic MN9D cells
[38]. In addition, Nurr1 is known to be essential for the survival
of maturing DA neurons by its induction of molecules required
for the expression of the DA phenotype [21]. Therefore, Nurr1
may enhance the generation of neurons at the level of neuronal
induction (‘neurogenesis’) and/or survival in the PA6 coculture
protocol. Further investigations are needed to clarify this. Sec-
ondly, our results demonstrate that SDIA, Nurr1, and signaling
molecules can synergistically enhance the differentiation of
ESCs to the DA fate. In our optimized condition II, we observed
that the majority (up to 90%) of Tuj1 neurons were TH (and
AADC) after 14 days of in vitro differentiation. When com-
pared side by side with the PA6 coculture protocol in this study,
the five-stage method reproducibly results in a significantly
Figure 4. Electrophysiological properties of neurons differentiated
from N2SM (II) cells. (A): Current-clamp recordings during pro-
longed depolarizing current injections. Top traces represent current
injections, whereas bottom traces indicate voltage recordings. Depolar-
izing current injections elicited fast action potentials. (B): Voltage-
dependent membrane currents. Depolarizing voltage steps (top traces)
elicited outward K currents and fast inward Na currents. (C): Cur-
rent-clamp recordings during prolonged hyperpolarizing current injec-
tions. The neurons display the time-dependent anomalous rectification
characteristic of dopaminergic neurons after a hyperpolarizing pulse.
Abbreviation: SM, signaling molecule.
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lower population of TH/Tuj1 cells (approximately 60%) and
requires twice as long (4 weeks) for the full cycle of in vitro
differentiation [24]. Taken together, combined with a higher
yield of neurons only in PA6 coculture method, our optimized
condition II represents a very effective protocol for efficient
generation of DA neurons in a short period of time.
Our coimmunostaining and gene expression analysis indi-
cate that those TH neurons generated from our optimal in vitro
differentiation have midbrain DA neuronal properties. First, all
TH neurons tested were found to be AADC, suggesting that
they have the ability to synthesize DA. Some of these neurons
also coexpressed DAT, whereas none of them express other
neurotransmitter markers such as 5-HT and GABA. Absence of
GABA is characteristic of midbrain DA neurons, whereas ol-
factory DA neurons coexpress TH and GABA. Analyses of
mRNAs from these neurons by semiquantitative and real-time
PCR revealed a robust upregulation of DAT, AADC, and Girk2
mRNAs (Figs. 3A, 3B). However, other midbrain DA markers
such as AHD2 and Pitx3 were only minimally upregulated,
suggesting that additional factor(s)/signal(s) may be necessary
for full maturation of these DA neurons. In this context, it is of
great interest that Pitx3-overexpressing ESC lines can generate
a significantly higher proportion of AHD2/TH neurons [39].
An important physiological criterion of a functional DA
neuron is the ability to release synthesized DA in response to
membrane depolarization. When compared with naı¨ve D3 cells,
these N2-derived neurons not only expressed higher levels of
intracellular DA (18-fold) but also efficiently released it into
the medium either spontaneously (14-fold) or in response to
depolarization induced by high KCl (fourfold) (Fig. 5). Thus,
N2 cells under our optimized condition II have the ability to
efficiently differentiate into functional midbrain DA neurons in
vitro. Furthermore, differentiated cells exhibit typical excitable
properties of neuronal membrane (e.g., firing of action poten-
tials and existence of fast inward Na current) (Figs. 4A, 4B).
In addition, the majority of differentiated cells subjected to
hyperpolarizing voltage steps showed anomalous rectification
(Fig. 4C), which is the electrophysiological characteristic of
mesencephalic DA neurons [35, 36].
Interestingly, a majority of TH	 neurons generated from N2
cells were 5-HT (data not shown; Fig. 2B). In addition, our
semiquantitative and real-time PCR analyses showed a threefold
upregulation of TPH mRNA levels, a key enzyme involved in
serotonin synthesis. In agreement with this, in vitro differenti-
ated cells from N2 cells were able to produce and release
significantly higher levels of serotonin than D3 ESCs (data not
Figure 5. Analyses of dopamine synthesis and release. Results of HPLC analyses of dopaminergic (DA) levels in 24 hour–conditioned media, 50 mM
KCl-challenged media, and intracellular fractions of D3 and N2SM (II) cells are shown. Each group represents an average of six samples. Fisher’s PLSD
post hoc analysis was performed with a significance level of 0.05. *p  .05 compared with D3 cells. Abbreviation: PLSD, protected least-significant
difference.
Figure 6. Evaluation of conditions for transplantation. (A): Embryonic stem cells (ESCs) stop growing after approximately 8–9 days of differentiation.
ESCs (1.05 104) were plated on PA6 feeder layer of 6-cm culture dish at differentiation day 0. After differentiation for the indicated times, ESC colonies
were isolated from the feeder layer by incubation with papain (1.5 ml/6 cm dish) for 5 minutes, dissociated into single cells, suspended in 5 ml of medium,
and counted. (B): Cell viability after isolation using papain treatment. At the indicated days, ESC colonies were isolated from the feeder layer by incubation
with papain (1.5 ml/6 cm dish) for 5 minutes, dissociated into single cells suspensions, replated onto poly-L-ornithine/fibronectin plates, and counted after
12 hours. Starting cell numbers were expressed as 100%. (C): The number of tyrosine hydroxylase (TH) cells increased dramatically on induction day 9.
At the indicated days, ESC colonies were isolated from the feeder layer by incubation with papain (1.5 ml/6 cm dish) for 5 minutes, dissociated into single
cells, replated onto poly-L-ornithine/fibronectin plates, and stained with anti-TH antibodies after 12 hours.
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shown). Thus, it is likely that some factors/signals regulating the
development of DA and 5-HT neurons overlap in our in vitro
differentiation system, as is the case in the in vivo situation [40, 41].
Finally, with the long-term goal of translating our in vitro
studies to the cell replacement therapy of PD, we transplanted DA
neurons generated from our optimized condition. Toward this goal,
we first defined the optimal in vitro differentiation period by
assessing cell proliferation, viability, and generation of TH neu-
rons under our differentiation condition II. We determined that the
optimal time for transplantation is the ninth day of N2 cell differ-
entiation, when the total cell number reaches the maximum with
high cell survival rate. At this time, the number of TH neurons is
suboptimal and neurites have not been formed extensively (Fig. 6),
which may reduce the damage resulting from the dissociation
procedure prior to transplantation. When 50,000 cells were har-
vested at day 9 and transplanted into the striatum of mice, we
observed an approximately 10-fold increase in the number of TH
neurons of N2 cell grafts compared with D3 cell grafts.
In conclusion, these results suggest that DA neurons generated
under in vitro conditions described in the present protocol may be
useful as a cell source for in vivo cell transplantation studies. Two
research groups have shown that the hESCs can differentiate into
neuronal cell types in vitro [42, 43]. More recently some of these
hESCs were shown to differentiate into DA neurons in vitro using
different procedures [15–17, 44]. However, the maturity and func-
tion of hESC–derived DA neurons are to be fully characterized in
vitro and in vivo. Importantly, recent reports demonstrated that
pluripotent hESCs can be derived from cloned blastocysts through
somatic cell nuclear transfer technology [45, 46]. Therefore, it is of
great interest to determine whether the optimized protocol we
describe here can also be applied to improve the generation of DA
neurons from these hESCs.
SUMMARY
The present study sought to optimize the differentiation of ESCs to
the DA cell fate by combining genetic manipulation and in vitro
culture conditions. When Nurr1-overexpressing ESCs were cocul-
tured with PA6 stromal cells and treated with signaling molecules
(i.e., Shh, FGF8, ascorbic acid), we found that ESCs generate a
significantly higher number of neurons (twofold) and that the
majority (up to 90%) of them become TH. Optimal induction of
the DA fate was also confirmed by real-time PCR analysis of
mRNA expression, characterization of electrophysiological prop-
erties, and the analysis of the production and release of DA.
Furthermore, transplantation experiments showed that TH neu-
rons generated by our optimal condition can efficiently integrate
into mouse striatum after implantation. Thus, this study shows that
combination of genetic manipulation(s) and in vitro cell differen-
tiation conditions offers a reliable and effective induction of DA
neurons from ESCs and may serve as a platform for future cell
transplantation therapy in PD.
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